Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors

被引:0
|
作者
Gerhard König
Peter Chiba
Gerhard F. Ecker
机构
[1] University of Vienna,Emerging Field Pharmacoinformatics, Department of Medicinal Chemistry
[2] Medical University of Vienna,Institute of Medical Chemistry
关键词
Computer chemistry; Propafenone; Multidrug resistance; Molecular modeling; Antitumor agents.;
D O I
暂无
中图分类号
学科分类号
摘要
Lipophilicity is one of the major determining physicochemical descriptors for P-glycoprotein (P-gp) inhibitory activity. In order to consider lipophilicity as a space directed property, we apply the concept of hydrophobic moments on a set of propafenone-type inhibitors of P-glycoprotein and use them as descriptors in QSAR analyses. While the 0th moment is the sum of the atomic hydrophobicity coefficients, which is a measure for the total hydrophobicity of the molecule, the 1st moment (or hydrophobic dipole) is a measure for the asymmetry of the distribution of hydrophobicities and therefore is analogous to the electrostatic dipole. The use of these hydrophobic dipole moments as independent variables remarkably improved the predictive power of QSAR models obtained.
引用
收藏
页码:401 / 405
页数:4
相关论文
共 50 条
  • [21] Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors
    Voigt, Burkhardt
    Coburger, Claudius
    Monar, Josef
    Hilgeroth, Andreas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) : 5110 - 5113
  • [22] STRUCTURE-ACTIVITY-RELATIONSHIP STUDIES ON MODULATORS OF THE MULTIDRUG TRANSPORTER P-GLYCOPROTEIN - AN OVERVIEW
    ECKER, G
    CHIBA, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1995, 107 (22) : 681 - 686
  • [23] Activators of P-glycoprotein: Structure-Activity Relationships and Investigation of their Mode of Action
    Sterz, Katja
    Moellmann, Lars
    Jacobs, Anna
    Baumert, Dieter
    Wiese, Michael
    CHEMMEDCHEM, 2009, 4 (11) : 1897 - 1911
  • [24] Structure-activity relationships of transmembrane inhibitors of P-glycoprotein.
    Tarasova, N
    Seth, R
    Michejda, CJ
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6072S - 6072S
  • [25] Structure-activity relationship studies of sphingosine kinase inhibitors
    Raje, Mithun R.
    Kharel, Yugesh
    Lynch, Kevin R.
    Santos, Webster L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [26] Reversal of multidrug resistance by derivatives of acrivastine: A study of structure-activity relationships of P-glycoprotein inhibitors in vitro and in vivo
    Christensen, JG
    Parks, LG
    McNutt, RW
    LeBlanc, GA
    ONCOLOGY REPORTS, 1997, 4 (06) : 1353 - 1360
  • [27] COVALENT INHIBITORS OF P-GLYCOPROTEIN ATPASE ACTIVITY
    ALSHAWI, MK
    URBATSCH, IL
    SENIOR, AE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (12) : 8986 - 8992
  • [28] Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series
    Etievant, C
    Schambel, P
    Guminski, Y
    Barret, JM
    Imbert, T
    Hill, BT
    ANTI-CANCER DRUG DESIGN, 1998, 13 (04): : 317 - 336
  • [29] Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein
    Bain, LJ
    McLachlan, JB
    LeBlanc, GA
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (08) : 812 - 818
  • [30] STUDIES ON THE ATPASE ACTIVITY OF P-GLYCOPROTEIN
    ALSHAWI, MK
    SENIOR, AE
    FASEB JOURNAL, 1993, 7 (07): : A1154 - A1154